Drug Trial Radar · NCT05079919
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
617
Actual
Start
Oct 25, 2021
Primary completion
Oct 22, 2024
Study completion Jul 8, 2025
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Oct 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
Conditions
- Severe Hypertriglyceridemia
Interventions
OlezarsenDrug
Olezarsen will be administered by SC injection.
PlaceboDrug
Olezarsen-matching placebo will be administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Fasting TG Compared to PlaceboTime frame: Baseline and Month 6
Locations
209 sites in 23 countries. Site status is shown where the registry gives one.
Accel Research Sites Network
Birmingham, Alabama
Mayo Clinic
Scottsdale, Arizona
Velocity Clinical Research
Chula Vista, California
Diabetes/Lipid Management & Research Center
Huntington Beach, California
University of California, San Diego (UCSD)
La Jolla, California
LA Universal Research Center, Inc.
Los Angeles, California
America Clinical Trials
Tarzana, California
Excel Medical Clinical Trials, LLC
Boca Raton, Florida
Southeast Clinical Research LLC
Chiefland, Florida
Westside Center for Clinical Research
Jacksonville, Florida
Finlay Medical Research
Miami, Florida
Innovia Research Center, INC
Miramar, Florida
Ocala Cardiovascular Research
Ocala, Florida
IMA Clinical Research
St. Petersburg, Florida
VICIS Clinical Research
Tampa, Florida
Bayside Clinical Research
Trinity, Florida
IACT Health
Columbus, Georgia
IMA Clinical Research Chicago
Chicago, Illinois
Affinity Health
Oak Brook, Illinois
West Broadway Clinic
Council Bluffs, Iowa
Kansas University Medical Center
Kansas City, Kansas
Clinical Trials of America, LLC
Monroe, Louisiana
Continental Clinical Solutions
Towson, Maryland
University of Michigan Hospital and Health Systems/ Dept. of Pharmacy-Research Pharmacy
Ann Arbor, Michigan
Aa Mrc, Llc
Flint, Michigan
Washington University School of Medicine
St Louis, Missouri
IMA Clinical Research
St Louis, Missouri
Bryan Medical Center Clinical Research
Lincoln, Nebraska
Palm Research Center, INC.
Las Vegas, Nevada
Hudson County Clinical Trials Research Center
Union City, New Jersey
Modern Medicine
Brooklyn, New York
Northwell Health
Great Neck, New York
Circuit Clinical (Crystal Run Healthcare)
Middletown, New York
NYU Langone
New York, New York
Columbia University
New York, New York
Circuit Clinical
Niagara Falls, New York
Modern Medical
Syosset, New York
Novant Health Cancer Institute Elizabeth Investigational Drug Services
Charlotte, North Carolina
Cone Medical Center
Greensboro, North Carolina
Clinical Trials of America, LLC
Mount Airy, North Carolina
Showing 40 of 209 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.